rs2300272

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000834.5(GRIN2B):​c.412-49730C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.446 in 152,080 control chromosomes in the GnomAD database, including 16,277 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.45 ( 16277 hom., cov: 34)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.504

Publications

11 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.541 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GRIN2BNM_000834.5 linkc.412-49730C>T intron_variant Intron 3 of 13 ENST00000609686.4 NP_000825.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GRIN2BENST00000609686.4 linkc.412-49730C>T intron_variant Intron 3 of 13 1 NM_000834.5 ENSP00000477455.1
GRIN2BENST00000630791.3 linkc.412-49730C>T intron_variant Intron 4 of 14 5 ENSP00000486677.3
GRIN2BENST00000714048.1 linkn.412-49730C>T intron_variant Intron 3 of 12 ENSP00000519339.1

Frequencies

GnomAD3 genomes
AF:
0.446
AC:
67797
AN:
151962
Hom.:
16273
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.279
Gnomad AMI
AF:
0.495
Gnomad AMR
AF:
0.454
Gnomad ASJ
AF:
0.607
Gnomad EAS
AF:
0.262
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.456
Gnomad MID
AF:
0.516
Gnomad NFE
AF:
0.546
Gnomad OTH
AF:
0.494
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.446
AC:
67828
AN:
152080
Hom.:
16277
Cov.:
34
AF XY:
0.441
AC XY:
32820
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.279
AC:
11555
AN:
41480
American (AMR)
AF:
0.454
AC:
6937
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.607
AC:
2108
AN:
3470
East Asian (EAS)
AF:
0.262
AC:
1357
AN:
5172
South Asian (SAS)
AF:
0.478
AC:
2301
AN:
4818
European-Finnish (FIN)
AF:
0.456
AC:
4825
AN:
10574
Middle Eastern (MID)
AF:
0.510
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
0.546
AC:
37107
AN:
67984
Other (OTH)
AF:
0.491
AC:
1037
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1877
3754
5632
7509
9386
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
624
1248
1872
2496
3120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.523
Hom.:
35327
Bravo
AF:
0.438
Asia WGS
AF:
0.410
AC:
1425
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.43
DANN
Benign
0.47
PhyloP100
-0.50
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2300272; hg19: chr12-13956579; API